In the US, there are nearly 300,000 children with juvenile arthritis and other rheumatic illnesses. For pediatric patients with systemic juvenile idiopathic arthritis (JIA), effective treatment for this disabling disease is imperative. New treatment recommendations that guide physicians caring for children with systemic JIA are now published.